Thermo to Collaborate With NextGen Sciences | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific's Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center will collaborate with NextGen Sciences to apply new technologies to that company's biomarker assay services, Thermo announced today.

The BRIMS Center will work with NextGen Sciences to add new technologies to the company's biomarkerexpress platform — a set of biomarker services that rely on a mass spectrometry-based approach called selected reaction monitoring to assay proteins and peptides in biofluids and tissues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.